RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ONCR
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

ONCR Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Dec 26, 2023 Dec 26, 2023 Dec 29, 2023 $0.139 110.58%

FAQ

What is the symbol for Oncorus, Inc. Stock and on which exchange is it traded?
The symbol for Oncorus, Inc. is ONCR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Oncorus, Inc. Stock?
Oncorus, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Oncorus, Inc. Stock?
Oncorus, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Oncorus, Inc. Stock.

What's the current price of Oncorus, Inc. Stock?
As of the end of day on the 2024-03-28, the price of an Oncorus, Inc. (ONCR) share was $0.126.

What is the 52-week high and low for Oncorus, Inc. Stock?
The 52-week high for Oncorus, Inc. Stock is $0.398 and the 52-week low is $0.0100.

What is the market capitalization of Oncorus, Inc. Stock?
As of the 2024-03-28, the market capitalization of Oncorus, Inc. is 3.288M.

When is the next earnings date for Oncorus, Inc.?
The upcoming earnings date for Oncorus, Inc. is May 20, 2024.
Click to get the best stock tips daily for free!

About Oncorus, Inc.

Oncorus. Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various cancers. It is also developing ONCR-GBM, a preclinical stage oHSV program for treating brain cancer through... ONCR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT